Research & Education

IASLC European Webinar Series - 2015/2016 - Lung Cancer in Women

Tuesday, November 10, 2015 - 7 p.m. CET - Recording Available
Silvia Novello

Silvia Novello MD, PhD
Associate Professor
Department of Oncology
University of Turin

Name of Reviewer(s): 

              

Fred Hirsch, MD, PhD –Speakers Bureau/Advisory Board: Astrazeneca, Genentech, BMS, Lilly and Abbvie.

Name of Planner(s): 

 

     Deb Whippen-Nothing to Disclose

 

Name of Activity: 

 

Lung Cancer in Women

Date of Activity:

 

11/10/2015

Faculty/Speaker(s):

Financial DISCLOSURES

 

Moderator – Franco Foti – Nothing to Disclose

Speaker- Silvia Novello MD, PhD-Nothing to Disclose

Type of Activity: 

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?

           No

If yes, please list:

 

For several decades, lung cancer has been considered a neoplastic disease affecting mainly men; however, during the past 40 years, the incidence of the disease has increased exponentially among women.
 
The presentation will cover:

  • Epidemiologic changer regarding gender and lung cancer;
  • Smoking habit as the first risk factor for lung cancer also in women;
  • Lung cancer in never smokers and gender issues
  • Overview on steroid hormones role in gender differences for lung cancer and other factors

After viewing this presentation, attendees will:

  • Understand that Lung Cancer is not a  "male disease" any more and Epidemiology is still changing
  • Learn that a Smoking habits are the primary cause of the increase in lung cancer rates among women
  • Recognize that Lung Cancer in Never smokers represents a different disease and women are the largest percentage of never-smokers who develop Lung Cancer
  • Be aware of potential factors involved in the biology of lung cancer in women

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

 

CME INFORMATION:

Financial/Commercial Relationships DISCLOSURES

A Conflict of Interest (COI) is created and exists when individuals in a position to control the content of CME, or their spouses/partners, that have a relevant personal financial relationship within the past 12 months with a commercial interest that produces, markets, re-sells, or distributes health care goods or services consumed by, or used, on patients that benefits the individual in any financial amount and therefore, may bias their opinions and teachings. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or any other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research and clinical trials), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities for which remuneration is received or expected. 

 This IASLC CME educational activity was planned and developed to: uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and, include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

IASLC CME assures that the planners/reviewers/authors/faculty/moderators/peer reviewers et. al. conflicts of interest  were identified, reviewed and resolved from all individuals involved in the development  or able to influence and control the content of this CME activity; IASLC CME assures that disclosure is given prior to an educational activity being delivered to learners.  Any individual who failed or refused to disclose relevant financial relationships was disqualified from this CME activity and removed from any of IASLC CME activity presentation.

All commercial relationships and conflicts of interest that are identified are thoroughly vetted by IASLC Ethics Committee, CME Subcommittee, and Independent reviewer. COI will be evaluated by the Board of Directors of the IASLC for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. IASLC CME is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial entity.

CREDIT STATEMENT

IASLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

IASLC CME designates this Internet Live Course activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

GOAL & PURPOSE

This activity will cover:

  • Epidemiologic changer regarding gender and lung cancer;
  • Smoking habit as the first risk factor for lung cancer also in women;
  • Lung cancer in never smokers and gender issues
  • Overview on steroid hormones role in gender differences for lung cancer and other factors

TARGET AUDIENCE

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.

DISCLAMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Thank you for your participation.

DOWNLOAD RECORDING

IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)

If you are interested in obtaining the CME Credits for these sessions you must indicate this when you register for the program. CME credit is only available to attendees of the live webinar.

Location Local time Time zone UTC offset
New York (U.S.A. - New York) Tuesday, November 10, 2015 at 1:00:00 PM EST UTC-5 hours
Rome (Italy) Tuesday, November 10, 2015 at 7:00:00 PM CET UTC+1 hour
London (United Kingdom) Tuesday, November 10, 2015 at 6:00:00 PM GMT UTC
Barcelona (Spain) Tuesday, November 10, 2015 at 7:00:00 PM CET UTC+1 hour
Amsterdam (Netherlands) Tuesday, November 10, 2015 at 7:00:00 PM CET UTC+1 hour
Dublin (Ireland) Tuesday, November 10, 2015 at 6:00:00 PM GMT UTC
Moscow (Russia) Tuesday, November 10, 2015 at 9:00:00 PM MSK UTC+3 hours
Brussels (Belgium) Tuesday, November 10, 2015 at 7:00:00 PM CET UTC+1 hour
Berlin (Germany) Tuesday, November 10, 2015 at 7:00:00 PM CET UTC+1 hour
Paris (France) Tuesday, November 10, 2015 at 7:00:00 PM CET UTC+1 hour
Corresponding UTC (GMT) Tuesday, November 10, 2015 at 6:00:00 PM     

How to use the Time Zone Converter